Free Trial

Top Growth Stocks Worth Watching - May 6th

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, Prologis, and Apollo Global Management are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at an above-average rate compared to the overall market. Investors buy these stocks anticipating that the companies will reinvest profits into expansion, innovation, or market penetration rather than paying out large dividends. Because of their high growth potential, these stocks often trade at higher price-to-earnings ratios. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NYSE:NVO traded down $2.58 during midday trading on Tuesday, hitting $66.54. 5,661,998 shares of the company traded hands, compared to its average volume of 6,226,809. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.62. The firm's fifty day moving average is $71.06 and its 200-day moving average is $87.22. The firm has a market capitalization of $298.59 billion, a P/E ratio of 20.21, a P/E/G ratio of 0.90 and a beta of 0.65. Novo Nordisk A/S has a 12-month low of $57.00 and a 12-month high of $148.15.

Read Our Latest Research Report on NVO

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Shares of Prologis stock traded down $0.48 during trading on Tuesday, hitting $104.85. The stock had a trading volume of 1,850,908 shares, compared to its average volume of 4,130,617. Prologis has a 12 month low of $85.35 and a 12 month high of $132.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.75 and a quick ratio of 0.43. The firm's fifty day simple moving average is $107.35 and its 200-day simple moving average is $111.70. The stock has a market cap of $97.29 billion, a PE ratio of 26.22, a PEG ratio of 2.70 and a beta of 1.25.

Read Our Latest Research Report on PLD

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

Apollo Global Management stock traded down $2.90 during midday trading on Tuesday, reaching $131.09. The stock had a trading volume of 1,303,517 shares, compared to its average volume of 3,838,772. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.33. The firm has a market cap of $74.78 billion, a price-to-earnings ratio of 17.92, a price-to-earnings-growth ratio of 1.17 and a beta of 1.66. Apollo Global Management has a 52-week low of $95.11 and a 52-week high of $189.49. The company has a fifty day moving average of $132.91 and a 200 day moving average of $152.97.

Read Our Latest Research Report on APO

Recommended Stories

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines